EBITDA Margin % is calculated as EBITDA divided by its Revenue. Metall Zug's EBITDA for the
six
months ended in Dec. 2025 was CHF-1.9 Mil. Metall Zug's Revenue for the
six
months ended in Dec. 2025 was CHF100.4 Mil. Therefore, Metall Zug's EBITDA margin for the quarter that ended in Dec. 2025 was -1.91%.
Metall Zug (XSWX:METN) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Metall Zug EBITDA Margin % Related Terms
Metall Zug EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Metall Zug's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:METN vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, Metall Zug's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Metall Zug EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Metall Zug's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Metall Zug's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Metall Zug (XSWX:METN) has a EBITDA Margin % of -1.91% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Metall Zug and its competitors. According to the industry distribution chart, Metall Zug ranks #520 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 63.8%.
Is Metall Zug's EBITDA Margin % too high?
Metall Zug's current EBITDA Margin % is -1.91%. Based on the distribution chart, Metall Zug ranks #520 out of 815 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Metall Zug has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Metall Zug's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Metall Zug ranks #520 out of 815 companies for EBITDA Margin %. This places Metall Zug in the lower half of its industry. The industry median EBITDA Margin % is 7.47. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.47, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Metall Zug and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Metall Zug's current EBITDA Margin % is -1.91%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metall Zug stock overvalued right now?
Based on GuruFocus' analysis, Metall Zug (XSWX:METN) is currently considered Fairly Valued. The stock's GF Value™ is CHF780.48, compared to a current price of CHF727.00 — trading 6.9% below its estimated fair value. The current EBITDA Margin % is -1.91%. Metall Zug's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Metall Zug (XSWX:METN), the current EBITDA Margin % is -1.91% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Metall Zug (XSWX:METN) Overvalued in 2026?
Based on GuruFocus' analysis, Metall Zug stock appears to be undervalued.
The current stock price of CHF727.00 is trading 6.9% below its estimated GF Value™ of CHF780.48.
GuruFocus considers Metall Zug to be Fairly Valued.
Key valuation signals for XSWX:METN:
EBITDA Margin %: -1.91%
GF Value™: CHF780.48 vs. price of CHF727.00 (6.9% below fair value)
No single metric tells the full story. See the XSWX:METN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Metall Zug Ltd is engaged in the industrial sector. The company is organized, into business segments namely; Medical Devices which comprises of products and services for diagnosis and surgery, mainly in the fields of ophthalmology and microsurgery; Technologycluster & Infrastructure is engaged in Management and development of real estate; and Investments & Corporate. The majority of its revenue is generated from the Medical Devices segment. Geographically, the company operates in Switzerland, Europe (excluding Switzerland), the Americas, and Asia /Pacific/Others, and the majority of its revenue is generated from the Americas region.
63GF Score
Get the complete analysis for XSWX:METN
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:METN has been successfully added to your 
